Advertisement
Advertisement
BSX
Boston Scientific Corp.
70.38
USDSponsored
+0.49
+0.70%
Mar 20, 11:02 UTC -4
Open
BSX Earnings Reports
Positive Surprise Ratio
BSX beat 32 of 40 last estimates.
80%
Next Report
Date of Next Report
Apr 21, 2026
Estimate for Q1 26 (Revenue/ EPS)
$5.23B
/$0.79
Implied change from Q4 25 (Revenue/ EPS)
-1.11%
/-1.25%
Implied change from Q1 25 (Revenue/ EPS)
+12.11%
/+5.33%
Boston Scientific Corp. earnings per share and revenue
On Feb 04, 2026, BSX reported earnings of 0.80 USD per share (EPS) for Q4 25, beating the estimate of 0.78 USD, resulting in a 1.61% surprise. Revenue reached 5.29 billion, compared to an expected 5.33 billion, with a -0.88% difference. The market reacted with a -17.59% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 22 analysts forecast an EPS of 0.79 USD, with revenue projected to reach 5.23 billion USD, implying an decrease of -1.25% EPS, and decrease of -1.11% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.26
Surprise
+98.02%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Boston Scientific Corp.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Boston Scientific Corp. reported EPS of $0.80, beating estimates by 1.61%, and revenue of $5.29B, -0.88% below expectations.
How did the market react to Boston Scientific Corp.'s Q4 2025 earnings?
The stock price moved down -17.59%, changed from $91.62 before the earnings release to $75.50 the day after.
When is Boston Scientific Corp. expected to report next?
The next earning report is scheduled for Apr 21, 2026.
What are the forecasts for Boston Scientific Corp.'s next earnings report?
Based on 22
analysts, Boston Scientific Corp. is expected to report EPS of $0.79 and revenue of $5.23B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement